Isoniazid is an antibiotic used for the treatment of tuberculosis. For active disease, it is often used together with rifampicin, pyrazinamide, and either streptomycin or ethambutol. However, for latent tuberculosis, it is commonly used by itself. Isoniazid is used with other medications to treat active disease (TB) infections. However, it is also used only to prevent active TB infections in people who may be infected with the bacteria (people with positive TB skin test). Also, isoniazid is an antibiotic and works by stopping the growth of bacteria.
MARKET DYNAMICS
The isoniazid market is boosting due to the rising geriatric population and growing chronic diseases. However, stringent regulations, and lack of skilled personnel with sound technical knowledge is restraining the market growth during the forecast period. Moreover, the rise in government initiatives to enhance health care facilities, is propelling the market growth in the forecast period.
MARKET SCOPE
The "Isoniazid Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of isoniazid market with detailed market segmentation by type and end user/application. The isoniazid market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in isoniazid market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The isoniazid market is segmented on the basis type and application/end user. Based on type, the market is segmented as above 98% isoniazid and below 98% isoniazid. On the basis of end use/application, the market is categorized as hospital, clinic and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the isoniazid market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The isoniazid market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting isoniazid market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the isoniazid market in these regions.
MARKET PLAYERS
The report covers key developments in the isoniazid market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from isoniazid market are anticipated to have lucrative growth opportunities in the future with the rising demand for isoniazid in the global market. Below mentioned is the list of few companies engaged in the isoniazid market.
he report also includes the profiles of key players in isoniazid market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AMSAL CHEM
- Resonance Specialties
- Calyx Pharma and Chem
- Camus pharma
- Titan Pharma (India)
- Taizhou Tianrui Pharmaceutical
- Zhejiang Second Pharma
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.